Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Edwards
A Lipp

Showing results (1071-1080 of 1,297) with videos related to

Pageof 130
Sort By:
Cancer Research|June 2, 2018
Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor MicroenvironmentMarie-Nicole Theodoraki, Saigopalakrishna Yerneni, Saumendra N Sarkar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 23, 2014
Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratificationJohn A Vargo, Hayeon Kim, Christopher J Houser, et al.
Vaccines|July 27, 2024
Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1Jennifer L Taylor, Kathleen M Kokolus, Per H Basse, et al.
Nature Communications|April 20, 2022
New seasonal pattern of pollution emerges from changing North American wildfiresRebecca R Buchholz, Mijeong Park, Helen M Worden, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2011
Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancerWilliam C Zamboni, Austin J Combest, Julie A DeLoia, et al.
Nature|August 28, 2014
A global strategy for road buildingWilliam F Laurance, Gopalasamy Reuben Clements, Sean Sloan, et al.
Nature Communications|May 12, 2025
Structural proteomics defines a sequential priming mechanism for the progesterone receptorMatthew D Mann, Min Wang, Josephine C Ferreon, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2018
The Prognostic Significance of p16 Status in Patients With Vulvar Cancer Treated With Vulvectomy and Adjuvant RadiationMichael J Dohopolski, Zachary D Horne, Dinesh Pradhan, et al.
NPJ Precision Oncology|July 19, 2023
Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibitionHussein Al-Sudani, Ying Ni, Philip Jones, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2006
The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitorsCheryl A Grice, Kevin Tays, Haripada Khatuya, et al.
Pageof 130

Showing results (1071-1080 of 1,297) with videos related to

Sort By:
Pageof 130
Cancer Research|June 2, 2018
Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor MicroenvironmentMarie-Nicole Theodoraki, Saigopalakrishna Yerneni, Saumendra N Sarkar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 23, 2014
Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratificationJohn A Vargo, Hayeon Kim, Christopher J Houser, et al.
Vaccines|July 27, 2024
Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1Jennifer L Taylor, Kathleen M Kokolus, Per H Basse, et al.
Nature Communications|April 20, 2022
New seasonal pattern of pollution emerges from changing North American wildfiresRebecca R Buchholz, Mijeong Park, Helen M Worden, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2011
Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancerWilliam C Zamboni, Austin J Combest, Julie A DeLoia, et al.
Nature|August 28, 2014
A global strategy for road buildingWilliam F Laurance, Gopalasamy Reuben Clements, Sean Sloan, et al.
Nature Communications|May 12, 2025
Structural proteomics defines a sequential priming mechanism for the progesterone receptorMatthew D Mann, Min Wang, Josephine C Ferreon, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2018
The Prognostic Significance of p16 Status in Patients With Vulvar Cancer Treated With Vulvectomy and Adjuvant RadiationMichael J Dohopolski, Zachary D Horne, Dinesh Pradhan, et al.
NPJ Precision Oncology|July 19, 2023
Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibitionHussein Al-Sudani, Ying Ni, Philip Jones, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2006
The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitorsCheryl A Grice, Kevin Tays, Haripada Khatuya, et al.
Pageof 130